![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, July 09, 2023 10:07:05 PM
“ Dear Mr Davis,
Thank you for your email and sorry to hear about your friend.
Unlike the situation in the US, we have been able to offer DCVax on a private self-pay basis to selected patients in the UK for many years now. I have many patients from the US who come to the UK to receive this treatment.
Please ask your friend/ his children to contact my PA, Salima, to arrange for a virtual or telephone consultation in the first instance so I can get the full history and also explain the process etc. Salima is on:
salima.makkaoui2@hcahealthcare.co.uk
Of course we will do our best to help if at all possible,
Best regards,
I am so grateful that he replied and can’t what to tell my friend Joel."
First of all, I'm happy for your friend, that there's hope.
second of all, is no one else pissed off at this?!!! We have been able to offer dc-vax in the UK for many years now to a selected few. Why is this not known to the public and especially to the doctors? If Joel had not had a friend who knows about dc-vax through Ihub, would Joel have known about this treatment? "For many years now", let that sink in. 2 friends of mine passed away from cancer. I told them to look up NWBO. I dont know if they ever did, but I'm guessing if they asked their doctors about it, they knew nothing. Posters keep asking "well what should they PR"?
How about "Unlike the situation in the US, we have been able to offer DCVax on a private self-pay basis to selected patients in the UK for many years now. I have many patients from the US who come to the UK to receive this treatment." for starters, followed by the success rate.
Even now, after they get approval, I don't have confidence they will know how to get the word out to the world.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM